Cannabidiol (CBD) is a natural compound that has been gaining traction in recent years due to its potential therapeutic benefits. It is being studied for its potential to help with a variety of mental health issues, including depression, anxiety, and opioid use disorder. While there is some evidence to suggest that CBD may be beneficial for certain mental health conditions, more research is needed to fully understand its effects. CBD is commonly used to control psychiatric symptoms, but up to 50% of psychiatric patients who use it do not report it to their doctors.
This highlights the perceived efficacy of consumers and the potential risks of unregulated, low-quality CBD products that may contain THC or have a composition that does not match the descriptions on the labels. A large-scale study on the use of CBD in the treatment of pediatric epilepsy found that it reduced the frequency of seizures by more than 50% in 43% of patients with Dravet syndrome. Research investigating the effects of CBD on certain conditions is ongoing and much remains to be learned about its potential uses. A study published in the Journal of Alternative and Complementary Medicine found that an oral dose of CBD, in addition to routine psychiatric treatment for post-traumatic stress disorder (PTSD), was associated with a reduction in symptoms.
Some research suggests that CBD may be effective for certain types of pain, such as nerve pain and back pain, when used alone. A study with adults with symptoms of anxiety and lack of sleep found that 65% experienced improvements in sleep quality scores after one month of taking an average of 25 mg of CBD per day. To help manufacturers harness the full potential of CBD-based therapies, DSM has created an innovation platform that facilitates early stage drug development. CBD and nabiximoles were effective in disorders related to cannabis use, and preliminary evidence was found to support their use for other psychiatric disorders. With more than 70 years of experience in producing and ensuring the supply of quality APIs, together with unique specialized services and customized solutions, DSM is the ideal partner for the development of purpose-built CBD-based pharmaceutical products that can support the mental health and well-being of patients at scale worldwide.
